Patent ID: 11884696
Assignee: SAGE THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 14:
15. A method for treating a CNS-related disorder, wherein the CNS-related disorder is a mood disorder, a psychotic disorder, an anxiety disorder, tremor, or tinnitus, in a subject in need thereof, comprising administering to the subject an effective amount of a crystalline solid Form C of Compound 1:, wherein the crystalline solid Form C of Compound 1 has an XRPD pattern comprising peaks at 9.9 degrees in 2θ, 14.8 degrees in 2θ, 17.0 degrees in 2θ, 20.7 degrees in 2θ, and 21.5 degrees in 2θ.